Cisplatin is a commonly used chemotherapy drug for advanced gastric cancer [51], and studies have shown that increased expression of c-Myc and c-Met sensitizes gastric cancercells to cisplatin treatment [52, 53]. This evidence concerns the gene MYC and gastric cancer.